AlloMend Extra-Large Acellular Dermal Matrix features our largest size available in an area of 320cm2 for demanding soft tissue applications. This versatile biologic scaffold supports incorporation, retains growth factors and maintains the extra-cellular components of native tissue. It features ultimate tensile strength exceeding that of leading acellular matrices, and high suture retention strength for more assurance in surgical repair of soft tissue.1,2

  • Available in meshed and non-meshed varieties
  • Flexible and pliable, offering desired handling characteristics to support precision placement
  • Terminal sterilization with e-beam technology to a Sterility Assurance Level (SAL)
    of 10-6, minimizing infection risk, while avoiding damaging the allograft tissue
  • Specific to the meshed version:
    • Features a 1cm non-meshed border for secure and easy suturing.
    • Meshing allows for graft expansion to provide adaptability with reconstruction procedures
    • Increased surface area verses non-meshed versions for potentially faster incorporation, enabling fluid egress to possibly guard against seroma formation

DermaTrue™ Decellularization Process
AlloMend is processed with AlloSource’s proprietary DermaTrue Decellularization Process to remove cellular debris (including DNA, RNA, proteins and antigens) rendering the tissue acellular, thus contributing to a low immunologic response1, while retaining growth factors and collagen structure.2

  1. Stilwell, R., Delaney, R. The biomechanics of AlloMend acellular dermal matrix: biocompatibility study. AlloSource White Paper. 2016.
  2. Delaney, R., Stilwell, R. The biologic properties of AlloMend acellular dermal matrix: growth factor study. AlloSource White Paper. 2016.